Your browser doesn't support javascript.
Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021.
Mooring, Eric Q; Newell, Katherine; Castrodale, Louisa; Tompkins, Megan; Frank, Morgan; McLaughlin, Joseph.
  • Mooring EQ; CDC COVID-19 Response, Anchorage, Alaska, USA.
  • Newell K; CDC COVID-19 Response, Anchorage, Alaska, USA.
  • Castrodale L; Epidemic Intelligence Service Officer, Anchorage, Alaska, USA.
  • Tompkins M; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.
  • Frank M; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.
  • McLaughlin J; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.
Clin Infect Dis ; 75(Supplement_2): S298-S302, 2022 Oct 03.
Article in English | MEDLINE | ID: covidwho-2051358
ABSTRACT
We compared the mortality risk in Alaska among persons with symptomatic coronavirus disease 2019 (COVID-19) during the period the Delta variant was predominant to the risk among those with symptomatic COVID-19 before Delta predominance. The Delta period was associated with 2.43-fold higher odds of death. Unvaccinated persons were 4.49 times more likely to die than fully vaccinated persons.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid